1.Bassetti, C, Velia, S, Donati, F, Wielepp, P, Weder, B. SPECT during sleepwalking. Lancet. 2000;356:484–485.
2.Huapaya, LV. Seven cases of somnambulism induced by drugs. Am J Psychiatry. 1979;136:985–986.
3.Kolivakis, TT, Margolese, HC, Beauclair, L, Chouinard, G. Olanzapine-induced somnambulism. Am J Psychiatry. 2001:158:1158.
4.Salin-Pascual, RJ, Herrera-Estrella, M, Galicia-Polo, L, Laurrabaqulo, MR. Olanzapine acute administration in schizophrenic patients increases delta sleep and sleep efficiency. Biol Psychiatry. 1999:46:141–143.
5.Sharpley, AL, Vassallo, CM, Cowen, PJ. Olanzapine increases slow-wave sleep: evidence for blockade of central 5-HT2C receptors in vivo. Biol Psychiatry. 2000;47:468–470.
6.Khazaal, Y, Krenz, S, Zullino, DF. Bupropion-induced somnambulism. Addict Biol. 2003;8:359–362.
7.Yang, W, Dollear, M, Muthukrishnan, SR. One rare side effect of zolpidem-sleep-walking: a case report. Arch Phys Med Rehabil. 2005:86:1265–1266.
8.Yanes Baonza, M, Ferrer García-Barras, JM, Cabrera Majada, A, Sánchez González, R. Sleep-walking linked to Zolpidem. Aten Primaria. 2003:32:438.
9.Sharma, A, Dewan, VK. A case report of zolpidem-induced somnambulism. J Clin Psychiatry. 2005:7:74.
10.Harazin, J, Berigan, TR. Zolpidem tartrate and somnambulism. Mil Med. 1999;164:669–670.
11.Sattar, SP, Ramaswamy, S, Bhatia, SC. Petty, F. Somnambulism due to probable Interaction of valproic acid and Zolpidem. Ann Pharmacother. 2003:37:1429–1433.
12.Varkey, BM, Varkey, LM. Topiramate induced somnabulism and automatic behavior. Indian J Med Sci. 2003;57:508–510.
13.Landry, P, Montplaisir, J. Lithium-induced somnambulism. Can J Psychiatry. 1998;43:957–958.
14.Trulson, ME, Jacobs, BL, Morrison, AR. Raphe unit activity during REM sleep in normal cats and in pontine lesioned cats displaying REM sleep without atonia. Brain Res. 1981;226:75–91.
15.Steinfels, GF, Heym, J, Strecker, RE, Jacobs, BL. Raphe unit activity in freely moving cats is altered by manipulation of central but not peripheral motor systems. Brain Res. 1983;279:77–84.
16.Juszczak, GR, Swiergiel, AH. Serotonergic hypothesis of sleepwalking. Med Hypotheses. 2005;64:28–32.
17.Wang, W, Bradley, SR, Richerson, GB. Quantification of the response of rat medullary raphe neurons to independent changes in pH(0) and P(C02). J Physiol. 2002;540:951–970.
18.Kales, JD, Kales, A, Soldates, CR, Chamberlin, K, Martin, ED. Sleepwalking and night terrors related to febrile illness. Am J Psychiatry. 1979;136:1214–1215.
19.Wegener, G, Bandpey, Z, Heiberg, IL, Mork, A, Rosenberg, R. Increased extracellular serotonin level in rat hippocampus induced by chronic Citalopram is augmented by subchronic lithium: neurochemical and behavioural studies in the rat. Psychopharmacol. 2003;166:188–194.
20.Price, LH, Charney, DS, Delgado, PL, Heninger, GR. Lithium and serotonin function: implications for the serotonin hypothesis of depression. Psychopharmacology (Berl). 1990;100:3–12.
21.Tharoor, H, Lobos, EA, Todd, RD, Reiersen, AM. Association of dopamine, serotonin, and nicotinic gene polymorphisms with methylphenidate response In ADHD. Am J Med Genet B Neuropsychiatr Genet. 2007 Oct 19; [Epub ahead of print].
22.Sheehan, K, Lowe, N, Kirley, A, et al.Tryptophan hydroxylase 2 (TPH2) gene variants associated with ADHD. Mol Psychiatry. 2005;10:944–949.
23.Li, J, Wang, Y, Zhou, R, et al.Association between tryptophan hydroxylase gene polymorphisms and attention deficit hyperactivity disorder in Chinese Han population. Am J Med Genet B Neuropsychiatr Genet. 2006;141:126–129.